Amgen Profit Rises 4% on 62% Revenue Increase

Amgen Inc. said its fiscal first-quarter profit rose 4% from a year earlier on a 62% revenue increase.

The biotechnology company, headquartered in Thousand Oaks, said net income in the quarter ended June 30 climbed to $494,000, or 3 cents a share, from $474,000, or 3 cents a share, a year earlier. Revenue rose to $12.6 million from $7.7 million.

The per-share results were unchanged because Amgen had an average 16.9 million common shares outstanding in the latest quarter, up from 14.9 million a year ago.